These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 35046456)

  • 1. A panel of emerging EMT genes identified in malignant mesothelioma.
    Wu L; Amjad S; Yun H; Mani S; de Perrot M
    Sci Rep; 2022 Jan; 12(1):1007. PubMed ID: 35046456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Omics Overview of the SPARC Gene in Mesothelioma.
    Wu L; de Perrot M
    Biomolecules; 2023 Jul; 13(7):. PubMed ID: 37509139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic Value of EMT Gene Signature in Malignant Mesothelioma.
    Wu L; Yoshihara K; Yun H; Karim S; Shokri N; Zaeimi F; Man HSJ; Zia A; Felley-Bosco E; de Perrot M
    Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Patient-Derived, Pan-Cancer EMT Signature Identifies Global Molecular Alterations and Immune Target Enrichment Following Epithelial-to-Mesenchymal Transition.
    Mak MP; Tong P; Diao L; Cardnell RJ; Gibbons DL; William WN; Skoulidis F; Parra ER; Rodriguez-Canales J; Wistuba II; Heymach JV; Weinstein JN; Coombes KR; Wang J; Byers LA
    Clin Cancer Res; 2016 Feb; 22(3):609-20. PubMed ID: 26420858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AEBP1 Is One of the Epithelial-Mesenchymal Transition Regulatory Genes in Colon Adenocarcinoma.
    Li D; Liu Z; Ding X; Qin Z
    Biomed Res Int; 2021; 2021():3108933. PubMed ID: 34938806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Establishing a Prognostic Signature Based on Epithelial-Mesenchymal Transition-Related Genes for Endometrial Cancer Patients.
    Liu J; Cui G; Shen S; Gao F; Zhu H; Xu Y
    Front Immunol; 2021; 12():805883. PubMed ID: 35095892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxia promotes acquisition of aggressive phenotypes in human malignant mesothelioma.
    Kim MC; Hwang SH; Kim NY; Lee HS; Ji S; Yang Y; Kim Y
    BMC Cancer; 2018 Aug; 18(1):819. PubMed ID: 30111297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of epithelial-mesenchymal transition markers in clear cell renal cell carcinoma.
    Xu H; Xu WH; Ren F; Wang J; Wang HK; Cao DL; Shi GH; Qu YY; Zhang HL; Ye DW
    Aging (Albany NY); 2020 Jan; 12(1):866-883. PubMed ID: 31915310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identifying global expression patterns and key regulators in epithelial to mesenchymal transition through multi-study integration.
    Parsana P; Amend SR; Hernandez J; Pienta KJ; Battle A
    BMC Cancer; 2017 Jun; 17(1):447. PubMed ID: 28651527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Epithelial-to-Mesenchymal Transition (EMT) in the Development and Metastasis of Malignant Pleural Mesothelioma.
    Ramundo V; Zanirato G; Aldieri E
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-652 inhibits acidic microenvironment-induced epithelial-mesenchymal transition of pancreatic cancer cells by targeting ZEB1.
    Deng S; Li X; Niu Y; Zhu S; Jin Y; Deng S; Chen J; Liu Y; He C; Yin T; Yang Z; Tao J; Xiong J; Wu H; Wang C; Zhao G
    Oncotarget; 2015 Nov; 6(37):39661-75. PubMed ID: 26498682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lysine demethylase 2A promotes the progression of ovarian cancer by regulating the PI3K pathway and reversing epithelial‑mesenchymal transition.
    Lu DH; Yang J; Gao LK; Min J; Tang JM; Hu M; Li Y; Li ST; Chen J; Hong L
    Oncol Rep; 2019 Feb; 41(2):917-927. PubMed ID: 30483796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epithelial-mesenchymal transition markers screened in a cell-based model and validated in lung adenocarcinoma.
    Song J; Wang W; Wang Y; Qin Y; Wang Y; Zhou J; Wang X; Zhang Y; Wang Q
    BMC Cancer; 2019 Jul; 19(1):680. PubMed ID: 31296175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Novel Therapeutic Strategy Targeting the Mesenchymal Phenotype of Malignant Pleural Mesothelioma by Suppressing LSD1.
    Wirawan A; Tajima K; Takahashi F; Mitsuishi Y; Winardi W; Hidayat M; Hayakawa D; Matsumoto N; Izumi K; Asao T; Ko R; Shimada N; Takamochi K; Suzuki K; Abe M; Hino O; Sekido Y; Takahashi K
    Mol Cancer Res; 2022 Jan; 20(1):127-138. PubMed ID: 34593606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The transcriptome signature analysis of the epithelial-mesenchymal transition and immune cell infiltration in colon adenocarcinoma.
    Heryanto YD; Imoto S
    Sci Rep; 2023 Oct; 13(1):18383. PubMed ID: 37884639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MTA1 promotes metastasis of MPM via suppression of E-cadherin.
    Xu C; Hua F; Chen Y; Huang H; Ye W; Yu Y; Shen Z
    J Exp Clin Cancer Res; 2015 Dec; 34():151. PubMed ID: 26689197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Pattern of RNA Editing Changes in Pleural Mesothelioma upon Epithelial-Mesenchymal Transition.
    Felley-Bosco E; Qi W; Jean D; Meiller C; Rehrauer H
    Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Correlation Between the Immune and Epithelial-Mesenchymal Transition Signatures Suggests Potential Therapeutic Targets and Prognosis Prediction Approaches in Kidney Cancer.
    Liang J; Liu Z; Zou Z; Tang Y; Zhou C; Yang J; Wei X; Lu Y
    Sci Rep; 2018 Apr; 8(1):6570. PubMed ID: 29700419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Collagen-rich stroma in aggressive colon tumors induces mesenchymal gene expression and tumor cell invasion.
    Vellinga TT; den Uil S; Rinkes IH; Marvin D; Ponsioen B; Alvarez-Varela A; Fatrai S; Scheele C; Zwijnenburg DA; Snippert H; Vermeulen L; Medema JP; Stockmann HB; Koster J; Fijneman RJ; de Rooij J; Kranenburg O
    Oncogene; 2016 Oct; 35(40):5263-5271. PubMed ID: 26996663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Knockdown of lncRNA GHET1 inhibits osteosarcoma cells proliferation, invasion, migration and EMT in vitro and in vivo.
    Yang W; Shan Z; Zhou X; Peng L; Zhi C; Chai J; Liu H; Yang J; Zhang Z
    Cancer Biomark; 2018; 23(4):589-601. PubMed ID: 30475755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.